Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S7EH
|
||||
Former ID |
DNCL001656
|
||||
Drug Name |
Fezakinumabx
|
||||
Synonyms |
Sirukumab
|
||||
Drug Type |
Antibody
|
||||
Indication | Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06] | Phase 3 | [525300] | ||
Company |
Pfizer New York, NY
|
||||
Target and Pathway | |||||
Target(s) | Interleukin-6 receptor | Target Info | [543592] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.